Erratum: Human skin penetration of a copper tripeptide in vitro as a function of skin layer (Inflammation Research (2011) 60 (79-86) DOI: 10.1007/s00011-010-0238-9);Human skin penetration of a copper tripeptide in vitro as a function of skin layer

Inflammation Research

Volumn 60, Issue 1, 2011, Pages 79-86

  Hostynek, Jurij J ^a   Dreher, Frank ^a   Maibach, Howard I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Absorption; Arthritis; Bioavailability; Copper complex; Depot; Inflammation

Indexed keywords

COPPER COMPLEX; GLYCYLHISTIDYLLYSINE CUPRATE DIACETATE; UNCLASSIFIED DRUG;

ARTICLE; CADAVER; CONTROLLED STUDY; DRUG PENETRATION; DRUG RETENTION; DRUG STRUCTURE; EPIDERMIS; HUMAN; HUMAN TISSUE; SKIN PENETRATION; SKIN PERMEABILITY; STRATUM CORNEUM; TOPICAL DRUG ADMINISTRATION; TRANSDERMAL DRUG ADMINISTRATION;

EID: 78651366293     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-011-0343-4     Document Type: Erratum

References (48)

1. DH Brown WE Smith JW Teape AJ Lewis 1980 Anti-inflammatory effects of some copper complexes J Med Chem 23 729 734 1:CAS:528:DyaL3cXlt1Gmtrk%3D 10.1021/jm00181a006 7401102
2. JRJ Sorenson 1979 Copper chelates as possible active forms of the antiarthritic agents J Med Chem 19 135 148 10.1021/jm00223a024
3. GE Jackson L Mkhonta-Gama A Voye M Kelly 2000 Design of copper-based anti-inflammatory drugs J Inorg Biochem 79 147 152 1:CAS:528: DC%2BD3cXjslyrs7s%3D 10.1016/S0162-0134(99)00171-3 10830859
4. F Pirot J Millet YN Kalia P Humbert 1996 In vitro study of percutaneous absorption, cutaneous bioavailability and bioequivalence of zinc and copper from five topical formulations Skin Pharmacol 9 259 269 1:CAS:528:DyaK28XmsV2guro%3D 10.1159/000211423 8896117
5. L Mazurowska K Nowak-Buciak M Mojski 2007 ESI-MS method for in vitro investigation of skin penetration by copper-amino acid complexes: from an emulsion through a model membrane Anal Bioanal Chem 38 1157 1163 10.1007/s00216-007-1345-5
6. L Mazurowska K Nowak-Buciak M Mojski 2007 ESI-MS study of the mechanism of glycyl-L-histidyl-L-lysine-Cu(II) complex transport through model membranes of stratum corneum Talanta 72 650 654 1:CAS:528:DC%2BD2sXktF2itb0%3D 10.1016/j.talanta.2006.11.034 19071668
7. L Mazurowska M Mojski 2008 Biological activities of selected peptides: skin penetration ability of copper complexes with peptides J Cosmet Sci 59 59 69 1:CAS:528:DC%2BD1cXkvFWlur4%3D 18350235
8. J Hadgraft G Rideout 1987 Development of model membranes for percutaneous absorption measurements. I. Isopropyl myristate Int J Pharm 39 149 156 1:CAS:528:DyaL2sXlvVentLY%3D 10.1016/0378-5173(87)90210-9
9. Schaefer H, Redelmeier TE. Permeability properties of the stratum corneum. In: Skin Barrier. Principles of percutaneous absorption. New York: Karger; 1996. pp. 87-117.
10. H Schaefer J Lademann 2001 The role of follicular penetration-a differential view Skin Pharmacol Appl Physiol 14 Suppl 1 23 27 10.1159/000056386
11. DS Orth J Widjaja L Ly N Cao WB Shapiro 1998 Stability of skin persistence of topical products Cosmet Toiletries 113 51 63
12. Finkey M, Appa Y, Bhandarkar S. Copper peptide and skin. In: Elsner P, Maibach HI, editors. Cosmeceutical and active cosmetics. New York: Taylor and Francis; 2005. p. 550-64.
13. R Milanino V Buchner 2006 Copper: role of the endogenous and exogenous metal on the development and control of inflammatory processes Rev Environ Health 21 153 215 1:CAS:528:DC%2BD2sXps1SgsQ%3D%3D 17243347
14. Sorenson JRJ, Berthon G. Copper potentiation of non-steroidal antiinflammatory drugs. In: Handbook of metal-ligand interactions in biological fluids, 1st edn. New York: Marcel Dekker, Inc.; 1995. pp. 1318-1356.
15. Chohan ZH, Iqbal MS, Iqbal HS, Scozzafava A, Supuran CT. Transition metal acetylsalycilates and their anti-inflammatory activity. J Enzyme Inhib Med Chem. 2002; l17:1787-89.
16. Williams DRJ, Furnival C, May PM. Computer analysis of low molecular weight copper complexes in biofluids. In: Sorenson JRJ, editor. Inflammatory diseases and copper. Clifton, NJ: Humana Press; 1982. p. 45-56.
17. HD Brown J Dunlop WE Smith J Teape AJ Lewis 1980 Total serum copper and ceruloplasmin levels following administration of copper aspirinate to rats and guinea-pigs Agents Actions 10 465 470 1:CAS:528:DyaL3MXktFOru7k%3D 10.1007/BF01968048 7211579
18. Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polymer Edn, vol. 19, no. 8. Leiden: Koninklijke Brill NV; 2008. pp. 969-988.
19. JH Freedman L Pickart B Weinstein WB Mims J Peisach 1982 Structure of the Glycidyl-L-histidyl-L-lysine-Copper(II) complex in solution Biochemistry 21 4540 4544 1:CAS:528:DyaL38XltVGktrk%3D 10.1021/bi00262a004 6291585
20. C Conato R Gavioli R Guerrini H Kozlowski P Mlynarz C Pasti F Pulidori M Remelli 2001 Copper complexes of glycyl-histidyl-lysine and two of its synthetic analogues: chemical behaviour and biological activity Biochim Biophys Acta 1526 199 210 1:CAS:528:DC%2BD3MXivFehsbw%3D 11325542
21. P Deschamps PP Kulkarni M Gautam-Basak B Sarkar 2005 The saga of copper(II)-L-histidine Coord Chem Rev 249 895 909 1:CAS:528:DC%2BD2MXivVKnt7w%3D 10.1016/j.ccr.2004.09.013
22. JJ Yourick ML Koenig DL Yourick RI Bronaugh 2004 Fate of chemicals in skin after dermal application: does the in vitro skin reservoir affect the estimate of systemic absorption? Toxicol Appl Pharmacol 195 309 320 1:CAS:528:DC%2BD2cXitFKmu7g%3D 10.1016/j.taap.2003.07.015 15020193
23. Reddy MB, Bunge AL. In: Bronaugh RL, Maibach HI, editors. Percutaneous absorption. 4th edn. New York: Marcel Dekker; 2005. pp. 165-176.
24. E Tur HI Maibach RH Guy 1991 Percutaneous penetration of methyl nicotinate at three anatomical sites: evidence for an appendageal contribution to transport? Skin Pharmacol 4 230 234 1:STN:280:DyaK387mt1eitQ%3D%3D 10.1159/000210956 1789984
25. RO Potts RH Guy ML Francoeur 1992 Routes of ionic permeability through mammalian skin Solid State Ionics 53-56 165 169 10.1016/0167-2738(92)90378-3
26. GC Mazzenga B Berner F Jordan 1992 The transdermal delivery of zwitterionic drugs II: the flux of zwitterionic salts J Contr Rel 20 163 170 1:CAS:528:DyaK38XltFygs7c%3D 10.1016/0168-3659(92)90162-K
27. M Sznitowska B Berner HI Maibach 1995 Percutaneous penetration of multipolar ions: evidence for porous transport Int J Pharm 123 41 45 1:CAS:528:DyaK2MXmvF2mtbw%3D 10.1016/0378-5173(95)00031-D
28. J Lademann N Otberg H Richter U Jacobi H Schaefer U Blume-Peytavi 2003 Folliculaere Penetration-Ein entscheidender Penetrationswegvon topisch applizierten Substanzen Hautarzt 54 321 323 1:STN:280:DC%2BD3s7ltFyiuw%3D%3D 12669202
29. HA Abramson MH Gorin 1940 The electrophoretic demonstration of the patent pores of the living human skin in relation to the charge of the skin J Phys Chem 44 1094 1102 1:CAS:528:DyaH3MXpt1Gj 10.1021/j150405a008
30. WB Shelley FM Melton 1949 Factors accelerating the penetration of histamine through normal intact skin J Invest Dermatol 13 61 72 1:CAS:528:DyaG3MXmtFWjug%3D%3D 10.1038/jid.1949.13
31. I Fridovich 1986 Superoxide dismutases Adv Enzymol 58 61 97 1:CAS:528:DyaL28XltFSktbc%3D 3521218
32. JRJ Sorenson 1989 Copper complexes offer a physiological approach to treatment of chronic diseases Progr Med Chem 26 437 568 1:CAS:528: DyaL1MXmt1Cltrs%3D 10.1016/S0079-6468(08)70246-7
33. JRJ Sorenson 1976 Some copper chelates and their antiinflammatory and antiulcer activities Inflammation 1 317 322 1:CAS:528:DyaE28XltFKktbk%3D 10.1007/BF00917871
34. GE Jackson PM May DR Williams 1978 Metal-ligand complexes involved in rheumatoid arthritis J Inorg Nucl Chem 40 1189 1194 1:CAS:528: DyaE1MXpslegsA%3D%3D 10.1016/0022-1902(78)80539-9
35. PM May PW Linder DR Williams 1977 Computer simulation of metal-ion equilibria in biofluids: models for the low-molecular-weight complex d istribution of calcium(II), magnesium(II), manganese(II), iron(III), copper(II), zinc(II), and lead(II) ions in human blood plasma J Chem Soc Dalton Trans 6 588 595 10.1039/dt9770000588
36. Furnival C, May PM, Williams DR. Models of low-molecular-weight copper(II) complexing equilibria in relation to rheumatoid arthritis. In: Rainsford KD, Brune K, Whitehouse MW, editors. Trace elements in the pathogenesis and treatment of inflammation. Basel: Birkhäuser Verlag; 1981. p. 241-57.
37. RJ Cousins 1985 Absorption, transport, and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin Physiol Rev 65 238 309 1:CAS:528:DyaL2MXktlGitLo%3D 3885271
38. Powanda MC. Systemic alterations in metal metabolism during inflammation as part of an integrated response to inflammation. Agents Actions 1981; Suppl 8:121-135.
39. Iyengar GV, Kollmer WE, Bowen HJM. The elemental composition of human tissues and body fluids. New York: Verlag Chemie; 1978.
40. R Milanino A Frigo LM Bamabara M Marrella U Moretti M Pasqualicchio 1993 Copper and zinc status in rheumatoid arthritis: studies on plasma, erythrocytes and urine, and relationship with disease activity markers and pharmacological treatment Clin Exp Rheumatol 11 271 281 1:STN:280:DyaK3szlvVGhtQ%3D%3D 8353981
41. Milanino R. Copper in medicine and personal care: a historical overview. In: Hostynek JJ, Maibach HI, editors. Copper and the skin. New York: Informa Healthcare; 2006. p. 149-60.
42. Harrison BJ. Copper jewelry and arthritis. In: Hostynek JJ, Maibach HI, editors. Copper and the skin. New York: Informa Healthcare; 2006. p. 237-66.
43. DP Fairlie MW Whitehouse 1991 Transdermal delivery of inorganic complexes as metal drugs or nutritional supplements Drug Des Discov 8 83 102 1:CAS:528:DyaK38XhtFegtbk%3D 1793777
44. SA Chernomorsky AB Segelman 1988 Biological activities of chlorophyll derivatives New Jersey Med 85 669 673 1:STN:280:DyaL1M%2FhsFelsw%3D%3D
45. DHSS 1985 Deodorant over-the-counter drug products for internal human use CFR 21, part 357 Fed Reg 50 25162 25167
46. RW Gorter M Butorac EP Cobian 2004 Examination of the cutaneous absorption of copper after the use of copper-containing ointments Am J Ther 11 453 458 10.1097/01.mjt.0000127148.83065.e5 15543084
47. RO Potts RH Guy 1992 Predicting skin permeability Pharm Res 9 663 670 1:CAS:528:DyaK38XktF2rs7c%3D 10.1023/A:1015810312465 1608900
48. Levin J, Maibach HI. Human skin buffering capacity: an overview. In: Zhai H, Wilhelm K-P, Maibach HI, editors. Dermatotoxicology. 7th ed. Boca Raton: CRC Press; 2000. p. 971-80.